| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| P798100 | MACKLIN | Phenoxybenzamine HCl | 10mM in DMSO | 125元/1ml; | 展开 |
|
| P864422 | MACKLIN | Phenoxybenzamine HCl | 98% | 245元/1g; 1021元/5g; 3002元/25g; | 展开 |
|
| D0158 | TCI | Phenoxybenzamine Hydrochloride | >98.0%(T) | 270元/1G; 3300元/25G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(T) | | 分子式/分子量 | C18H22ClNO・HCl = 340.29 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 3747029 | | PubChem物质ID | 87566885 | | Merck Index (14) | 7256 | | MDL编号 | MFCD00055152 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(Nonaqueous Titration) | min. 98.0 % | | Melting point | 135.0 to 140.0 ℃ |
物性(参考值) 安全信息 | 图形或危害标志 |   | | 信号词 | 警告 | | 危险性说明 | H302 : 吞咽有害。
H351 : 怀疑致癌。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。
P270 : 使用本产品时不要进食、饮水或吸烟。
P202 : 在阅读并明了所有安全措施前切勿搬动。
P201 : 使用前取得专用说明。
P264 : 作业后彻底清洗皮肤。
P280 : 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。
P308 + P313 : 如接触到或有疑虑：求医/就诊。
P301 + P312 + P330 : 如误吞咽：如感觉不适，呼叫急救中心/医生。漱口。
P405 : 存放处须加锁。
|
相关法规 |
| 192714 | J&K | Phenoxybenzamine Hydrochloride | 98%, 一种具有选择性的α-肾上腺受体和钙调蛋白抑制剂, 是一种常用的抗高血压药 | 523元/1G; 1205元/5G; | 展开 |
基本信息 | 分子式 | C18H22ClNO·HCl | | 分子量 | 340.29 | | MDL编码 | MFCD00055152 | | Beilstein | 3747029 | | 存储条件 | Freezer -20℃ |
产品描述 Phenoxybenzamine HCl是一种非选择性，不可逆α受体拮抗剂，IC50为550 nM。 靶点（IC50 & Targe） CAM α-adrenergic receptor,550nM 安全信息 | 图形或危害标志 |  | | 危险说明 | H302
H410 | | 防范说明 | P264
P270
P273
P301+P312
P330
P391
P501 | | UN号码 | 3077 | | 危险分类 | 9 | | 包装等级 | III | | RTECS | DP3750000 |
|
| B019 | Sigma-Aldrich | Phenoxybenzamine Hydrochloride | ≥97%, powder | 1485.01元/250 MG; | 展开 |
产品说明 包装 250 mg in glass bottle 生化/生理作用 钙调蛋白拮抗剂；α-肾上腺素受体拮抗剂。 特点和优势 这种化合物是ADME毒性研究的特色产品。点击此处发现更多特色ADME毒性产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。
该化合物由Wellspring开发。要浏览其他药物开发化合物和批准的药物/候选药物列表，单击此处。 基本信息 | 经验(实验)分子式 | C18H22ClNO · HCl | | 分子量 | 340.29 | | EC 号 | 200-569-7 | | MDL编号 | MFCD00055152 | | PubChem化学物质编号 | 24277760 |
产品性质 | 质量水平 | 100 | | 测定 | ≥97% | | 形式 | powder | | 颜色 | white | | 溶解性 | H2O: slightly soluble
alcohol: soluble
propylene glycol: soluble | | 创始人 | Wellspring | | 储存温度 | 2-8℃ | | SMILES string | Cl[H].CC(COc1ccccc1)N(CCCl)Cc2ccccc2 | | InChI | 1S/C18H22ClNO.ClH/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17;/h2-11,16H,12-15H2,1H3;1H | | InChI key | VBCPVIWPDJVHAN-UHFFFAOYSA-N | | Gene Information | human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 - H351 | | 预防措施声明 | P201 - P301 + P312 + P330 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Carc. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges |
|
| PHR1402 | Supelco | Phenoxybenzamine Hydrochloride | Pharmaceutical Secondary Standard; Certified Reference Material | 839.6元/1 G; | 展开 |
产品说明 一般描述 Phenoxybenzamine Hydrochloride is an important drug belonging to the class of β-chloroethylamine drugs. It functions as an α-blocker by binding to α-adrenoreceptors, located on vascular smooth muscles and stops the influence of sympathetic nerves on blood vessels. It is widely used in the treatment of hypertension, benign prostatic hyperplasia and hypoplastic left heart syndrome.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. 应用 These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Phenoxybenzamine Hydrochloride may be used as a pharmaceutical reference standard in the determination of the analyte in pharmaceutical formulations by chromatographic and chemiluminescence techniques. 生化/生理作用 钙调蛋白拮抗剂；α-肾上腺素受体拮抗剂。 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAA2196 in the slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C18H22ClNO · HCl | | 分子量 | 340.29 | | EC 号 | 200-569-7 | | MDL编号 | MFCD00055152 | | PubChem化学物质编号 | 329823375 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material
pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable
gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to USP 1526007 | | 储存温度 | 2-30℃ | | SMILES string | Cl[H].CC(COc1ccccc1)N(CCCl)Cc2ccccc2 | | InChI | 1S/C18H22ClNO.ClH/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17;/h2-11,16H,12-15H2,1H3;1H | | InChI key | VBCPVIWPDJVHAN-UHFFFAOYSA-N | | Gene Information | human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 - H351 | | 预防措施声明 | P201 - P301 + P312 + P330 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Carc. 2 | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP1072 | | Phenoxybenzamine Hydrochloride | British Pharmacopoeia (BP) Reference Standard | 2144.18元/100 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 钙调蛋白拮抗剂；α-肾上腺素受体拮抗剂。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C18H22ClNO · HCl | | 分子量 | 340.29 | | MDL编号 | MFCD00055152 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Cl[H].CC(COc1ccccc1)N(CCCl)Cc2ccccc2 | | InChI | 1S/C18H22ClNO.ClH/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17;/h2-11,16H,12-15H2,1H3;1H | | InChI key | VBCPVIWPDJVHAN-UHFFFAOYSA-N | | Gene Information | human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 - H351 | | 预防措施声明 | P201 - P202 - P264 - P280 - P308 + P313 - P501 | | 危险分类 | Acute Tox. 4 Oral - Carc. 2 | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1526007 | USP | Phenoxybenzamine Hydrochloride | United States Pharmacopeia (USP) Reference Standard | 3231.47元/250 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 钙调蛋白拮抗剂；α-肾上腺素受体拮抗剂。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here.
Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C18H22ClNO · HCl | | 分子量 | 340.29 | | MDL编号 | MFCD00055152 | | PubChem化学物质编号 | 329750803 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 15-25℃ | | SMILES string | Cl[H].CC(COc1ccccc1)N(CCCl)Cc2ccccc2 | | InChI | 1S/C18H22ClNO.ClH/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17;/h2-11,16H,12-15H2,1H3;1H | | InChI key | VBCPVIWPDJVHAN-UHFFFAOYSA-N | | Gene Information | human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 - H351 | | 预防措施声明 | P280 - P301 + P312 + P330 | | 危险分类 | Acute Tox. 4 Oral - Carc. 2 | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| M02323 | Fluorochem | Phenoxybenzamine.HCl | >99% | 792元/1g; 6952元/25g; | 展开 |
基本信息 | CAS Number | 63-92-3 | | MDL Number | MFCD00055152 | | Melting Point | 139℃ |
安全信息 | 图形或危害标志 | | | 危险性说明 | H302: Harmful if swallowed.
H351: Suspected of causing cancer ..
| | 防范说明 | P201: Obtain special instructions before use.
P202: Do not handle until all safety precautions have been read and understood.
P264: Wash hands thoroughly after handling.
P270: Do not eat, drink or smoke when using this product.
P281: Use personal protective equipment as required.
P301 + P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.
P308 + P313: IF exposed or concerned: Get medical advice/ attention.
P330: Rinse mouth.
P405: Store locked up.
P501: Dispose of contents/container to local regulations.
|
|
m.cnreagent.com